Appendix-1.
Top most cited articles in the past 20 years.
| # | Author / Title/ Journal | Citation |
|---|---|---|
| 1 | 169 Aiello LP, Avery Rl, Arrigg PG, Keyt BA, Jampel HD, et al. Vascular Endothelial Growth-Factor In Ocular Fluid Of Patients With Diabetic-Retinopathy And Other Retinal Disorders New England Journal Of Medicine. 1994 Dec 1; 331 (22): 1480-1487 |
1877 |
| 2 | 150 Adamis AP, Miller JW, Bernal MT, Damico DJ, Folkman J, et al. Increased Vascular Endothelial Growth-Factor Levels In The Vitreous Of Eyes With Proliferative Diabetic-Retinopathy American Journal Of Ophthalmology. 1994 OCT; 118 (4): 445-450 |
745 |
| 3 | 693 Shannon H, Duffy H, Dahms W, Mayer L, Brillion D, et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. NEW ENGLAND JOURNAL OF MEDICINE. 2000 FEB 10; 342 (6): 381-389 |
622 |
| 4 | 43 Dyck Pj, Kratz Km, Karnes Jl, Litchy Wj, Klein R, et al. The Prevalence By Staged Severity Of Various Types Of Diabetic Neuropathy, Retinopathy, And Nephropathy In A Population-Based Cohort - The Rochester Diabetic Neuropathy Study NEUROLOGY. 1993 APR; 43 (4): 817-824 |
518 |
| 5 | 472 Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes LANCET. 1998 JAN 3; 351 (9095): 28-31 |
393 |
| 6 | 1114 Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology. 2003 SEP; 110 (9): 1677-1682 |
372 |
| 7 | 917 Schrier RW, Estacio RO, Esler A, Mehler P Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes KIDNEY INTERNATIONAL. 2002 MAR; 61 (3): 1086-1097 |
367 |
| 8 | 1216 Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy FASEB JOURNAL. 2004 JUL; 18 (10): 1450-+ |
358 |
| 9 | 1043 Hammes HP, Du XL, Edelstein D, Taguchi T, Matsumura T, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy Nature Medicine. 2003 MAR; 9 (3): 294-299 |
343 |
| 10 | 650 Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition Proceedings Of The National Academy Of Sciences Of The United States Of America. 1999 SEP 14; 96 (19): 10836-10841 |
329 |
| 11 | 306 Mizutani M, Kern TS, Lorenzi M Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy Journal Of Clinical Investigation. 1996 JUN 15; 97 (12): 2883-2890 |
322 |
| 12 | 1187 Kempen JH, O'Colmam BJ, Leske C, Haffner SM, Klein R, et al. The prevalence of diabetic retinopathy among adults in the United States ARCHIVES OF OPHTHALMOLOGY. 2004 APR; 122 (4): 552-563 |
322 |
| 13 | 639 Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1 - A potential mechanism for vascular permeability in diabetic retinopathy and tumors JOURNAL OF BIOLOGICAL CHEMISTRY. 1999 AUG 13; 274 (33): 23463-23467 |
290 |
| 14 | 1530 Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy OPHTHALMOLOGY. 2006 OCT; 113 (10): 1695-1705 |
288 |
| 15 | 934 Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, et al. A common polymorphism in the 5 '-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes DIABETES. 2002 MAY; 51 (5): 1635-1639 |
286 |
| 16 | 557 Klein R, Klein BEK, Moss SE, Cruickshanks KJ The Wisconsin epidemiologic study of diabetic retinopathy: XVII - The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes OPHTHALMOLOGY. 1998 OCT; 105 (10): 1801-1815 |
279 |
| 17 | 800 Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis DIABETOLOGIA. 2001 FEB; 44 (2): 156-163 |
273 |
| 18 | 897 Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression FASEB JOURNAL. 2002 JAN; 16 (1): 438-+ |
257 |
| 19 | 158 Malecaze F, Clamens S, Simorrepinatel V, Mathis A, Chollet P, et al. Detection Of Vascular Endothelial Growth-Factor Messenger-Rna And Vascular Endothelial Growth Factor-Like Activity In Proliferative Diabetic-Retinopathy ARCHIVES OF OPHTHALMOLOGY. 1994 NOV; 112 (11): 1476-1482 |
247 |
| 20 | 138 Klein R, Klein Bek, Moss Se, Cruickshanks Kj The Wisconsin Epidemiologic-Study of Diabetic-Retinopathy .14. 10-Year Incidence and Progression of Diabetic-Retinopathy ARCHIVES OF OPHTHALMOLOGY. 1994 SEP; 112 (9): 1217-1228 |
244 |
| 21 | 1457 Spaide RF, Fisher YL Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage Retina-The journal Of Retinal And Vitreous Diseases. 2006 Mar; 26 (3): 275-278 |
242 |
| 22 | 1711 Keech AC, Mitchell P, Summonen PA, O'Day J, Davis TME, et al. Effect of fenofibrate on the Need for Laser Treatment for Diabetic Retinopathy (FIELD study): a Randomized Controlled Trial LANCET. 2007 NOV 17; 370 (9600): 1687-1697 |
229 |
| 23 | 356 Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy investigative Ophthalmology & Visual Science. 1997 Jan; 38 (1): 36-47 |
222 |
| 24 | 319 Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy - Early treatment diabetic retinopathy study (ETDRS) report 22 Archives Of Ophthalmology. 1996 SEP; 114 (9): 1079-1084 |
220 |
| 25 | 1388 Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy New England Journal Of Medicine. 2005 AUG 25; 353 (8): 782-792 |
220 |
| 26 | 197 Aldington SJ, Kohner Em, Meuer S, Klein R, Sjolie Ak Methodology For Retinal Photography And Assessment Of Diabetic-Retinopathy - The Eurodiab Iddm Complications StuDY Diabetologia. 1995 Apr; 38 (4): 437-444 |
219 |
| 27 | 511 Lieth E, Barber AJ, Xu BY, Dice C, Ratz MJ, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy DIABETES. 1998 May; 47 (5): 815-820 |
219 |
| 28 | 187 Klein R, Klein Bek, Moss Se, Cruickshanks Kj The Wisconsin Epidemiologic-Study of Diabetic-Retinopathy .15. The Long-Term Incidence of Macular Edema OPHTHALMOLOGY. 1995 JAN; 102 (1): 7-16 |
211 |
| 29 | 2283 Cheung N, Mitchell P, Wong TY Diabetic retinopathy LANCET. 2010 JUL 10; 376 (9735): 124-136 |
199 |
| 30 | 970 Stitt A, Gardiner TA, Anderson NL, Canning P, Frizzell N, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes DIABETES. 2002 SEP; 51 (9): 2826-2832 |
196 |
| 31 | 852 Kowluru RA, Tang J, Kern TS Abnormalities of retinal metabolism in diabetes and experimental galactosemia VII. Effect of long-term administration of antioxidants on the development of retinopathy Diabetes. 2001 AUG; 50 (8): 1938-1942 |
193 |
| 32 | 1081 Kramer HJ, Nguyen QD, Curhan G, Hsu CY Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus Jama-Journal Of The American Medical Association. 2003 JUN 25; 289 (24): 3273-3277 |
193 |
| 33 | 2285 Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, et al. Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. New England Journal Of Medicine. 2010 JUL 15; 363 (3): 233-244 |
186 |
| 34 | 486 Mizutani M, Gerhardinger C, Lorenzi M Muller cell changes in human diabetic retinopathy DIABETES. 1998 MAR; 47 (3): 445-449 |
185 |
| 35 | 205 Tarnow L, Cambien F, Rossing P, Nielsen Fs, Hansen Bv, et al. Lack Of Relationship Between An Insertion Deletion Polymorphism In The Angiotensin I-Converting Enzyme Gene And Diabetic Nephropathy And Proliferative Retinopathy In Iddm Patients DIABETES. 1995 MAY; 44 (5): 489-494 |
181 |
| 36 | 463 Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy DIABETOLOGIA. 1998 JAN; 41 (1): 47-53 |
179 |
| 37 | 724 Rungger-Brandle E, Dosso AA, Leuenberger PM Glial reactivity, an early feature of diabetic retinopathy Investigative Ophthalmology & Visual Science. 2000 JUN; 41 (7): 1971-1980 |
179 |
| 38 | 178 Shamoon H, Duffy H, Fleischer N, Engel S, Saenger P, et al. The Effect Of Intensive Diabetes Treatment On The Progression Of Diabetic-Retinopathy In Insulin-Dependent Diabetes-Mellitus - The Diabetes Control And Complications Trial Archives Of Ophthalmology. 1995 Jan; 113 (1): 36-51 |
176 |
| 39 | 216 Kohner Em, Patel V, Rassam Smb Role Of Blood-Flow And Impaired Autoregulation In The Pathogenesis Of Diabetic-Retinopathy DIABETES. 1995 Jun; 44 (6): 603-607 |
174 |
| 40 | 484 Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, et al. United kingdom prospective diabetes study, 30 - Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus ann associated risk factors Archives Of Ophthalmology. 1998 MAR; 116 (3): 297-303 |
174 |
| 41 | 981 Hammes HP, Lin JH, Renner O, Shani M, Lundqvist A, et al. Pericytes and the pathogenesis of diabetic retinopathy DIABETES. 2002 OCT; 51 (10): 3107-3112 |
174 |
| 42 | 537 Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study DIABETES CARE. 1998 AUG; 21 (8): 1230-1235 |
170 |
| 43 | 264 Javitt JC, Aiello LP Cost-effectiveness of detecting and treating diabetic retinopathy ANNALS OF INTERNAL MEDICINE. 1996 JAN 1; 124 (1): 164-169 |
167 |
| 44 | 1449 Wong TY, Klein R, Islam A, Frances M, Folsom AR, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States American Journal Of Ophthalmology. 2006 MAR; 141 (3): 446-455 |
165 |
| 45 | 313 Tachi N, Ogino N Vitrectomy for diffuse macular edema in cases of diabetic retinopathy American Journal Of Ophthalmology. 1996 AUG; 122 (2): 258-260 |
162 |
| 46 | 413 Ambati J, Chalam KV, Chawla DK, DAngio CT, Guillet EG, et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy Archives Of Ophthalmology. 1997 SEP; 115 (9): 1161-1166 |
162 |
| 47 | 290 Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, et al. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy - A video fluorescein angiography study Investigative Ophthalmology & Visual Science. 1996 APR; 37 (5): 886-897 |
160 |
| 48 | 485 Hammes HP, Lin JH, Bretzel RG, Brownlee M, Breier G Upregulation of the vascular endothelial growth factor vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat DIABETES. 1998 MAR; 47 (3): 401-406 |
159 |
| 49 | 769 Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia Investigative Ophthalmology & Visual Science. 2000 NOV; 41 (12): 3972-3978 |
158 |
| 50 | 1340 Krady JK, Basu A, Allen CM, Xu YP, LaNoue KF, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy DIABETES. 2005 MAY; 54 (5): 1559-1565 |
158 |
| 51 | 1405 Genuth S, Sun WJ, Cleary P, Sell DR, Dahms W, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes DIABETES. 2005 NOV; 54 (11): 3103-3111 |
152 |
| 52 | 843 Kern TS, Engerman RL Pharmacological inhibition of diabetic retinopathy - Aminoguanidine and aspirin DIABETES. 2001 JUL; 50 (7): 1636-1642 |
151 |
| 53 | 814 Jonas JB, Hayler JK, Sofker A, Panda-Jonas S Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy American Journal Of Ophthalmology. 2001 APR; 131 (4): 468-471 |
144 |
| 54 | 1905 Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials LANCET. 2008 OCT 18; 372 (9647): 1394-1402 |
142 |
| 55 | 1904 Sjolie AK, Klein R, Porta M, Orchard T, Fuller J, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial LANCET. 2008 OCT 18; 372 (9647): 1385-1393 |
141 |
| 56 | 480 Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early treatment diabetic retinopathy study report #18 Investigative Ophthalmology & Visual Science. 1998 Feb; 39 (2): 233-252 |
140 |
| 57 | 1023 Beck RW, Moke PS, Turpin AH, Ferris FL, Sangiovanni JP, et al. A computerized method of visual acuity testing: Adaptation of the early treatment of diabetic retinopathy study testing protocol American Journal Of Ophthalmology. 2003 FEB; 135 (2): 194-205 |
139 |
| 58 | 964 Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, et al. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy Embo Journal. 2002 AUG 15; 21 (16): 4307-4316 |
138 |
| 59 | 985 Walter T, Klein JC, Massin P, Erginay A A contribution of image processing to the diagnosis of diabetic retinopathy - Detection of exudates in color fundus images of the human retina ieee transactions on medical imaging. 2002 Oct; 21 (10): 1236-1243 |
136 |
| 60 | 437 Palmowski AM, Sutter EE, Bearse MA, Fung W Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram Investigative Ophthalmology & Visual Science. 1997 NOV; 38 (12): 2586-2596 |
134 |
| 61 | 1255 Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus - UKPDS 69 Archives Of Ophthalmology. 2004 NOV; 122 (11): 1631-1640 |
131 |
| 62 | 1257 Zheng L, Szabo C, Kern TS Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappa B DIABETES. 2004 NOV; 53 (11): 2960-2967 |
131 |
| 63 | 836 Hudson BI, Stickland MH, Futers TS, Grant PJ Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy DIABETES. 2001 JUN; 50 (6): 1505-1511 |
128 |
| 64 | 966 Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy American Journal Of Ophthalmology. 2002 SEP; 134 (3): 348-353 |
125 |
| 65 | 1367 Aiello LP The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy initial - Results of the protein kinase C beta inhibitor diabetic retinopathy study (PKC-DRS) multicenter randomized clinical trial DIABETES. 2005 JUL; 54 (7): 2188-2197 |
125 |
| 66 | 240 ELNER SG, ELNER VM, JAFFE GJ, STUART A, KUNKEL SL, et al. Cytokines In Proliferative Diabetic-Retinopathy And Proliferative Vitreoretinopathy Current Eye Research. 1995 NOV; 14 (11): 1045-1053 |
123 |
| 67 | 363 Sjolie AK, Stephenson J, Aldington S, Kohner E, Janka H, et al. Retinopathy and vision loss in insulin dependent diabetes in Europe - The EURODIAB IDDM complications study OPHTHALMOLOGY. 1997 FEB; 104 (2): 252-260 |
120 |
| 68 | 1188 Hammes HP, Lin JH, Wagner P, Feng Y, vom Hagen F, et al. Angiopoietin-2 causes pericyte dropout in the normal retina - Evidence for involvement in diabetic retinopathy DIABETES. 2004 APR; 53 (4): 1104-1110 |
120 |
| 69 | 1273 Kowluru RA, Odenbach S Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats DIABETES. 2004 DEC; 53 (12): 3233-3238 |
119 |
| 70 | 206 Chew Ey, Mills Jl, Metzger Be, Remaley Na, Jovanovicpeterson L, et al. Metabolic Control And Progression Of Retinopathy - The Diabetes In Early-Pregnancy Study Diabetes Care. 1995 May; 18 (5): 631-637 |
116 |
| 71 | 931 Joussen AM, Poulaki V, Tsujikawa A, Qin WY, Qaum T, et al. Suppression of diabetic retinopathy with angiopoietin-1 American Journal Of PathologY. 2002 MAY; 160 (5): 1683-1693 |
115 |
| 72 | 694 Vijan S, Hofer TP, Hayward RA Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus JAMA-journal of the American Medical Association. 2000 FEB 16; 283 (7): 889-896 |
114 |
| 73 | 813 Bursell SE, Cavallerano JD, Cavallerano AA, Clermont AC, Birkmire-Peters D, et al. Stereo nonmydriatic digital-video color retinal imaging compared with early treatment diabetic retinopathy study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy OPHTHALMOLOGY. 2001 MAR; 108 (3): 572-585 |
114 |
| 74 | 1003 Goebel W, Kretzchmar-Gross T Retinal thickness in diabetic retinopathy - A study using optical coherence tomography (OCT) RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES. 2002 DEC; 22 (6): 759-767 |
114 |
| 75 | 1557 Abraham P, Adelman RA, Alfaro DV, Anand R, Antoszyk A, et al. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy OPHTHALMOLOGY. 2006 DEC; 113 (12): 2221-2230 |
114 |
| 76 | 1541 Jorge R, Costa RA, Comt DC, Cintra LP, Scott IU Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE Study) RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES. 2006 NOV-DEC; 26 (9): 1006-1013 |
112 |
| 77 | 219 KO BCB, LAM KSL, WAT NMS, CHUNG SSM An (A-C)(N) Dinucleotide Repeat Polymorphic Marker At The 5'-End Of The Aldose Reductase Gene Is Associated With Early-Onset Diabetic-Retinopathy In Niddm Patients DIABETES. 1995 JUL; 44 (7): 727-732 |
111 |
| 78 | 1179 Lyons TJ, Jenkins AJ, Zheng DY, Lackland DT, McGee D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2004 MAR; 45 (3): 910-918 |
109 |
| 79 | 273 Peer J, Folberg R, Itin A, Gnessin H, Hemo I, et al. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy BRITISH JOURNAL OF OPHTHALMOLOGY. 1996 MAR; 80 (3): 241-245 |
108 |
| 80 | 1759 Arevalo JF, Maia M, Flynn HW, Saravia M, Avery RL, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy BRITISH JOURNAL OF OPHTHALMOLOGY. 2008 FEB; 92 (2): 213-216 |
108 |
| 81 | 268 Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy BRITISH JOURNAL OF OPHTHALMOLOGY. 1996 FEB; 80 (2): 168-173 |
106 |
| 82 | 510 Boulton M, Foreman D, Williams G, McLeod D VEGF localisation in diabetic retinopathy BRITISH JOURNAL OF OPHTHALMOLOGY. 1998 MAY; 82 (5): 561-568 |
106 |
| 83 | 2300 Zhang XZ, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, et al. Prevalence of Diabetic Retinopathy in the United States, 2005-2008 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2010 AUG 11; 304 (6): 649-656 |
106 |
| 84 | 1347 Giebel SJ, Menicucci G, McGuire PG, Das A Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier LABORATORY INVESTIGATION. 2005 MAY; 85 (5): 597-607 |
104 |
| 85 | 901 Sinthanayothin C, Boyce JF, Williamson TH, Cook HL, Mensah E, et al. Automated detection of diabetic retinopathy on digital fundus images DIABETIC MEDICINE. 2002 FEB; 19 (2): 105-112 |
102 |
| 86 | 1176 Ray D, Mishra M, Ralph S, Read I, Davies R, et al. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes DIABETES. 2004 MAR; 53 (3): 861-864 |
102 |
| 87 | 1482 Oshima Y, Sakaguchi H, Gomi F, Tano Y Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy AMERICAN JOURNAL OF OPHTHALMOLOGY. 2006 JUL; 142 (1): 155-158 |
102 |
| 88 | 331 Gardner GG, Keating D, Williamson TH, Elliott AT Automatic detection of diabetic retinopathy using an artificial neural network: A screening tool BRITISH JOURNAL OF OPHTHALMOLOGY. 1996 NOV; 80 (11): 940-944 |
101 |
| 89 | 626 Hammes HP, Alt A, Niwa T, Clausen JT, Bretzel RG, et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy DIABETOLOGIA. 1999 JUN; 42 (6): 728-736 |
101 |
| 90 | 641 Brown MM, Brown GC, Sharma S, Shah G Utility values and diabetic retinopathy AMERICAN JOURNAL OF OPHTHALMOLOGY. 1999 SEP; 128 (3): 324-330 |
101 |
| 91 | 1247 Klein BEK, Klein R, McBride PE, Cruickshanks KJ, Palta M, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes - Wisconsin epidemiologic study of diabetic retinopathy ARCHIVES OF INTERNAL MEDICINE. 2004 SEP 27; 164 (17): 1917-1924 |
101 |
| 92 | 956 Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: A comparison with ophthalmoscopy and standardized mydriatic color photography AMERICAN JOURNAL OF OPHTHALMOLOGY. 2002 AUG; 134 (2): 204-213 |
100 |
| 93 | 1073 Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population DIABETES CARE. 2003 JUN; 26 (6): 1731-1737 |
100 |
| 94 | 655 Fortune B, Schneck ME, Adams AJ Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 1999 OCT; 40 (11): 2638-2651 |
99 |
| 95 | 1021 Younis N, Broadbent DM, Vora JP, Harding SP Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study LANCET. 2003 JAN 18; 361 (9353): 195-200 |
99 |
| 96 | 459 Yu T, Mitchell P, Berry G, Li WN, Wang JJ Retinopathy in older persons without diabetes and its relationship to hypertension ARCHIVES OF OPHTHALMOLOGY. 1998 JAN; 116 (1): 83-89 |
98 |
| 97 | 707 Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-DeHoff R, et al. The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy - A randomized controlled study DIABETES CARE. 2000 APR; 23 (4): 504-509 |
98 |
| 98 | 799 Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes - The EURODIAB Prospective Complications Study DIABETES CARE. 2001 FEB; 24 (2): 284-289 |
98 |
| 99 | 1502 Zhang SX, Wang JJ, Gao GQ, Parke K, Ma JX Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy JOURNAL OF MOLECULAR ENDOCRINOLOGY. 2006 AUG; 37 (1): 1-12 |
98 |
| 100 | 494 Mitchell P, Smith W, Wang JJ, Attebo K Prevalence of diabetic retinopathy in an older community - The Blue Mountains Eye Study OPHTHALMOLOGY. 1998 MAR; 105 (3): 406-411 |
97 |
The numbers before the article indicate the location of the article on the histogram map.